Issue
Alert me when new journal issues are available via or via
Proffered papers: Breast cancer I
1 ORAL The characteristics of invasive breast cancer in women who use and do not use hormone replacement therapy in the Million Women Study T. Gathani, J. Green, G. Reeves, V. Beral page S2 Full-Text PDF (60 KB)
2 ORAL Magnetic Resonance Imaging (MRI) in the preoperative assessment of patients with lobular carcinoma of the breast M.C. Kokke, A. Kyriazopoulos, J.C. Wissing, M.B.J.M. Korst, M.J.C.M. Rutten, W.A.H. Gelderman, K. Bosscha page S2 Full-Text PDF (60 KB)
3 ORAL Prognostic value of Mib-1 proliferation index in breast cancer. A prospective study on 669 patients A. Neri, D. Marrelli, E. Pinto, A. De Stefano, F. Mariani, C. Pedrazzani, S. Caruso, G. De Marco, T. Cioppa, F. Roviello page S2 Full-Text PDF (60 KB)
4 ORAL Achieving breast conservation with 1 mm pathological tumour free margin M. Khan, R. Ganga, P. Mansour, S. Meehan, S. Jmor pages S2-S3 Full-Text PDF (77 KB)
5 ORAL A very low recurrence rate is achieved by a targeted intraoperative radiotherapy (TARGIT) boost after breast conserving surgery for cancer J. Vaidya, M. Baum, M. Tobias JS Keshtgar, F. Wenz, S. Massarut, O. Murphy, B. Hilaris, U. Kraus-Tiefenbacher, T. Corica, D. Joseph page S3 Full-Text PDF (62 KB)
6 ORAL Comparative analysis of bone marrow micrometastases (BMM) with sentinel lymph node (SLN) status in early stage breast cancer (BrCA) S. Saha, D. Iddings, K. Doan, D. Wiese, E. Kang, L. Gallardo, A. Henke page S3 Full-Text PDF (62 KB)
Proffered papers: Colorectal cancer I
7 ORAL Incidence of hereditary colorectal cancer and microsatellite instability in the Padova area (Italy) S. Pucciarelli, E. Urso, M. Agostini, R. Bertorelle, A. Viel, G. Fabris, I. Maretto, D. Nitti page S3 Full-Text PDF (62 KB)
8 ORAL Endothelin-1 stimulates colorectal cancer adjacent fibroblasts J. Knowles, M. Loizidou, M. Dashwood, D. Abraham, S. Xu, I. Taylor page S4 Full-Text PDF (62 KB)
9 ORAL Impact of UK pilot colorectal screening programme on the profile of detection and staging of cancers: experience from a pilot district general hospital K. Kunal, K. Kochar, C. Vijaysekar, V. Jhadav, G. Mathew page S4 Full-Text PDF (62 KB)
10 ORAL Prognostic implications of lymphatic mapping in colorectal cancer (CRCa) - a multi-institutional trial S. Saha, E. Kang, T. Beutler, C. Hehner, A. Bilchik, D. Wiese, M. Ghanem, R. Sehgal, M. Patel page S4 Full-Text PDF (62 KB)
11 ORAL What is the location of the involved (extra)mesorectal lymph nodes in primary rectal cancer? S. Engelen, M. Lahaye, R. Beets-Tan, M. von Meyenfeldt, G. Beets page S4 Full-Text PDF (62 KB)
12 ORAL Pooled analysis of five large European randomised clinical trials (n=5158) on rectal cancer to identify surgery related parameters affecting outcome M. den Dulk, H. Putter, L. Collette, C.A.M. Marijnen, L. Påhlman, C. Bujko, C. Rödel, J.F. Bosset, C.J.H. van de Velde page S5 Full-Text PDF (63 KB)
13 ORAL Prognostic factors influencing the outcome of 1652 patients with colon or rectal cancer receiving adjuvant 5-FU-based chemotherapy M. Kornmann, L. Staib, S. Sander, D. Henne-Bruns, K.H. Link page S5 Full-Text PDF (63 KB)
14 ORAL Low local recurrence rate with multimodality treatment for distal rectal cancer P.M. van Schaik, W.A.H. Gelderman, E.A. Kouwenhoven, K. Bosscha page S5 Full-Text PDF (63 KB)
15 ORAL Does 18F-FDG PET/CT alter the management of patients with colorectal liver metastases? F. Pakzad, A. Engledow, S. Rogers, J.B. Bomanji, P.J. Ell, I. Taylor page S6 Full-Text PDF (60 KB)
Proffered papers: Colorectal cancer II
16 ORAL Nurse led flexible sigmoidoscopy in a satellite clinic: solution for NHS T. Singhal, S. Doddi, T. Ansari, C. DeSilva, F. Smedley page S6 Full-Text PDF (60 KB)
17 ORAL Factors affecting failed localisation and false-negative rates of ex-vivo sentinel lymph node mapping in colorectal cancer A. Sommariva, B. Gnocato, M. Tollot, M. Renier, G. Leoni, S. Ardit, V. Stracca Pansa, C. Tremolada page S6 Full-Text PDF (60 KB)
18 ORAL Quality of life after abdominoperineal resection and anterior resection of the rectum G. Rudinskaite, E. Stratilatovas page S6 Full-Text PDF (60 KB)
19 ORAL A standardised surgical technique for laparoscopic Total Mesorectal Excision: the implications of a ten years experience D. Claeys, K. Cathenis, D. De Mey, F. Muysoms page S7 Full-Text PDF (125 KB)
20 ORAL Titration of serum p53 autoantibodies in patients with colorectal cancer and the clinical significance of post-operative monitoring A. Takeda, Y. Yoshihide Otani, I. Isamu Koyama page S7 Full-Text PDF (125 KB)
21 ORAL Response to neoadjuvant therapy and prognosis in locally advanced rectal cancer C. Staudacher, S. Di Palo, A. Tamburini, G. Vitali, E. Orsenigo pages S7-S8 Full-Text PDF (188 KB)
22 ORAL How good is MRI after neo-adjuvant chemoradiation of locally advanced rectal cancer? G. Beets, R. Vliegen, G. Lammering, E. Dresen, H. Rutten, K. Oei, A. Kessels, A. De Bruïne, M. von Meyenfeldt, R. Beets-Tan page S8 Full-Text PDF (109 KB)
23 ORAL Adjuvant chemotherapy for stage III (sIII) colon cancer in the canadian atlantic provinces. What is the economic impact of capecitabine versus 5FU/LV? K. Virik, C. Skedgel, T. Younis page S8 Full-Text PDF (109 KB)
24 ORAL Modulation of adjuvant 5-FU treatment by folinic acid and interferon-alpha in colon and rectal cancer: Comparison of two phase-III trials including 1652 patients K. Link, L. Staib, W. Baumann, M. Redenbacher, S. Sander, D. Henne-Bruns, M. Kornmann pages S8-S9 Full-Text PDF (128 KB)
Proffered papers: Sentinel node biopsy
25 ORAL A randomized clinical trial on sentinel node biopsy versus axillary lymph node dissection in breast cancer: early results of the Sentinella/GIVOM trial G. Zavagno, P. Del Bianco, G. Scalco, L. Barutta, P. Burelli, P. Carraro, G. Tacchetti, R. Mencarelli, G.L. De Salvo, D. Nitti page S9 Full-Text PDF (65 KB)
26 ORAL Morbidity comparison of sentinel lymph node procedure versus conventional axillary lymph node dissection for breast cancer patients: results of Sentinella - GIVOM, an Italian randomized clinical trial G.L. De Salvo, P. Del Bianco, R. Marconato, F. Bozza, C. Racano, P. Pietrarota, G. Meneghini, D. Casara, D. Nitti, G. Zavagno pages S9-S10 Full-Text PDF (80 KB)
27 ORAL Sentinel lymph node biopsy using a blue dye directed technique alone leads to a high false negative rate O.J. Greene, K.J. Whannel, W.D. George, C.R. Wilson, J.C. Doughty page S10 Full-Text PDF (63 KB)
28 ORAL Validation and limitations of use of a Breast Cancer Nomogram predicting the likelihood of non-sentinel node involvement after positive sentinel node biopsy S. Alran, Y. De Rycke, V. Fourchotte, H. Charitansky, M. Falcou, P. Freneaux, M. Benamor, B. Sigal Zafrany, R. Salmon page S10 Full-Text PDF (63 KB)
Proffered papers: Cytoreductive surgery
29 ORAL Radioimmunotherapy is an effective adjuvant therapy to cytoreductive surgery for peritoneal carcinomatosis of Colonic Origin F. Aarts, M.J. Koppe, T. Hendriks, W.J.G. Oyen, O.C. Boerman, R.P. Bleichrodt page S10 Full-Text PDF (63 KB)
30 ORAL Radioimmunotherapy as adjuvant treatment of peritoneal carcinomatosis of colonic origin is at least as effective as HIPEC F. Aarts, T. Hendriks, J. Eerd-Vismale van, W.J.G. Oyen, O.C. Boerman, R.P. Bleichrodt pages S10-S11 Full-Text PDF (78 KB)
31 ORAL Treatment of peritoneal carcinomatosis by cytoreductive surgery and intraperitoneal hyperthermic chemoperfusion (IHCP). Postoperative complications and preliminary survival data F. Roviello, D. Marrelli, A. Neri, C. Pedrazzani, D. Cerretani, T. Cioppa, G. Corso, G. Giorgi, E. Pinto page S11 Full-Text PDF (64 KB)
32 ORAL Cytoreduction and hypertermic intraperitoneal chemotherapy in the treatment of peritoneal surface malignancy: reduced toxicity and morbidity J. Abreu de Sousa, M. Serralva, H. Silva, R. Fael, C. Lopes, M. Fragoso, D. Pereira, F. Cerejo, A. Martins, F. Faria page S11 Full-Text PDF (64 KB)
Proffered papers: Oesophageal and gastric cancer
33 ORAL Centralization of oesophageal resections for cancer: does it actually improve clinical outcome? M. Wouters, H. Karim, B. Wijnhoven, L. Stassen, W.H. Steup, H. Tilanus, R. Tollenaar pages S11-S12 Full-Text PDF (80 KB)
34 ORAL Value of noncurative resection in gastric cancer with peritoneal metastasis K. Yong Jin, K. Byung Sik page S12 Full-Text PDF (64 KB)
35 ORAL Results of Ivor Lewis Esophagectomy for mid and distal esophageal cancer: a single center experience S. Reremoser, W. Ceelen, O. Varin, J. Gillardin, E. Monsaert, M. Peeters, P. Pattyn page S12 Full-Text PDF (64 KB)
36 ORAL Prognostic significance of involved circumferential resection margin in resected oesophageal cancer A.A. Avantunde, I.N. Soomro, J.P. Duffy, N.T. Welch, S.L. Parsons page S12 Full-Text PDF (64 KB)
37 ORAL Extended (D2) and superextended (D3) lymphadenectomy for gastric cancer. Postoperative outcome and risk factors for complications D. Marrelli, C. Pedrazzani, A. Neri, G. Corso, A. De Stefano, E. Pinto, F. Roviello pages S12-S13 Full-Text PDF (79 KB)
38 ORAL Combined modality treatment for locally advanced oesophageal squamous cell carcinoma G. Lázár, K. Szentpáli, A. Paszt, G. Uhercsák, Z. Kahán page S13 Full-Text PDF (62 KB)
Proffered papers: Soft tissue sarcoma
39 ORAL Extrathoracic solitary fibrous tumours: outcome of 31 consecutive cases P. Gikas, I. Cranshaw, C. Fisher, J. Thomas, A. Hayes page S13 Full-Text PDF (62 KB)
40 ORAL The surgical management and outcome of patients over 80 years of age with soft tissue sarcoma A.J. Hayes, R. Boden, M. Clark, J.M. Thomas pages S13-S14 Full-Text PDF (77 KB)
41 ORAL Retroperitoneal sarcomas: a single institution experience F. Pacelli, A.P. Tortorelli, F. Rosa, V. Papa, M. Covino, G.B. Doglietto page S14 Full-Text PDF (63 KB)
42 ORAL Radiation-induced soft-tissue sarcoma: a decade of experience in a specialist unit M. Clark, S. Neuhaus, N. Pinnock, V. Giblin, C. Fisher, M. Thomas pages S14-S15 Full-Text PDF (77 KB)
43 ORAL The Swiss experience with isolated limb perfusion with high-doses tumor necrosis factor-alpha and melphalan, a limb salvage strategy for non-resectable soft tissue sarcomas of the extremities S. Cherix, M. Speiser, M. Matter, L. Guillou, D. Liénard, F. Lejeune, R. Mirimanoff, S. Leyvraz, P. Leyvraz page S15 Full-Text PDF (63 KB)
44 ORAL The clinicopathological characteristics of GIST of the rectum S. Maruyama, T. Tani, T. Iiai, V. Valera, Y. Koyama, T. Kanda, K. Hatakeyama, Y. Ajioka page S15 Full-Text PDF (63 KB)
Proffered papers: Melanoma
45 ORAL “N-ratio” as a novel prognostic factor for patients with stage III cutaneous melanoma C.R. Rossi, S. Mocellin, L.G. Campana, S. Pasquali, M. Foletto, M. Lise, D. Nitti page S15 Full-Text PDF (63 KB)
46 ORAL False negative sentinel node and overall survival in patients with cutaneous melanoma C. Caraco page S16 Full-Text PDF (60 KB)
47 ORAL Should sentinel lymph node micrometastases in skin melanoma be ignored? J. Vargas Moniz, V. Farricha, R. Casaca, M.J. Gomes, L. Manoel, J. Leal Faria, J. Bivar Weinholtz, J. Menesese Sousa page S16 Full-Text PDF (60 KB)
48 ORAL Is it possible to identify patients at risk for metastatic non sentinel lymph node (SLN) in melanoma patients? M. Matter, A. D'Ambroggio, M. Alloua, A. Boubaker, D. Liénard, O. Gugerli, J. Cerottini, D. Guggisberg, F. Lejeune page S16 Full-Text PDF (60 KB)
49 ORAL Improvement of survival: prognostic factors in relapsed cutaneous melanoma patients A.B. Francken, H.M. Shaw, S.J. Soong, N.A. Accortt, J.F. Thompson pages S16-S17 Full-Text PDF (74 KB)
50 ORAL Follow up of patients with clinically localised melanoma appears useless O.E. Nieweg, J. Wittenberg, B.B.R. Kroon page S17 Full-Text PDF (59 KB)
Proffered papers: Thyroid cancer
51 ORAL Surgical technique of sentinel lymph node biopsy in differentiated thyroid cancer using methilen blue dye - video presentation R. Dzodic, I. Markovic, M. Inic, N. Jokic, I. Djurisic, M. Zegarac, G. Pupic, Z. Milovanovic, V. Jovic, N. Jovanovic page S17 Full-Text PDF (59 KB)
52 ORAL Prophylactic lymph node dissection can be avoided for papillary thyroid carcinomas P. Kauffmann, S. Crestani, P. Gimbergues, C. Dejax, G. Fouilhoux, J. Dauplat page S17 Full-Text PDF (59 KB)
53 ORAL Prophylactic thyroidectomy during childhood in MEN 2 patients in the Netherlands J.M.J. Schreinemakers, M.R. Vriens, I.H.M. Borel Rinkes pages S17-S18 Full-Text PDF (77 KB)
54 ORAL Prediction of recurrence in parotid gland carcinoma J.F. Carrillo, R. Vazquez, F.J. Ochoa-Carrillo, L.F. Oñate-Ocaña, R. Herrera-Goepfert R page S18 Full-Text PDF (62 KB)
55 ORAL Angiosarcoma of the head and neck: an 18 year experience V. Agrawal, S. Mansuri, A. Singh, J. Staiano, A. Searle, P. Harris, P. Clarke page S18 Full-Text PDF (62 KB)
56 ORAL Lipofilling as aesthetic and functional refinement for superficial parotidectomy P. Vico pages S18-S19 Full-Text PDF (80 KB)
Poster session: Experimental surgical oncology
57 POSTER Nanosurgery of cancer with the aid of intracellular, nanoengineered antibodies against antioxidative enzymes M. Malecki, G. Konat, J. Pietruszkiewicz page S19 Full-Text PDF (65 KB)
58 POSTER Application of Boron-Entrapped WOW Emulsion as boron delivery carrier for boron neutron capture therapy on VX-2 rabbit hepatic cancer model H. Yanagie, S. Higashi, I. Ikushima, R. Nishimura, R. Mizumachi, Y. Murata, Y. Morishita, T. Kajiyama, A. Shinohara, M. Eriguchi page S19 Full-Text PDF (65 KB)
59 POSTER The combination of radiation and direct intratumoral injection of dendritic cells enhance systemic antitumor effect Y. Akutsu, H. Matsubara, T. Ochiai page S19 Full-Text PDF (65 KB)
60 POSTER Bioengineering reconstruction of the upper respiratory tract using tissue-equivalent in the rabbit I. Reshetov, V.I. Chissov, A.V. Vasiljev, E.V. Batuchtina, O.S. Rogovaya page S20 Full-Text PDF (62 KB)
Copyright © 2010 Elsevier, Inc. All rights reserved | Privacy Policy | Terms & Conditions | Feedback | About Us | Help | Contact Us | The content on this site is intended for health professionals.
